News

Medtronic, SYMPLICITY AF, PVI, renal denervation, Arctic Front, Spyral, G3

Medtronic plc announced the start of a clinical study to determine whether paroxysmal and persistent atrial fibrillation (AF) can be treated with a combination of two ablation procedures targeting...

therapeutic hypothermia, children, cardiac arrest, treatment, temperature

A large-scale, multicenter study has shown that therapeutic hypothermia does not improve survival rates or reduce brain injury in infants and children with out-of-hospital cardiac arrest more than...

Vessix Renal Denervation System, REDUCE-HTN: REINFORCE, high blood pressure

Boston Scientific Corp. is taking a new approach to evaluate the performance of the Vessix Renal Denervation System, initiating a study to isolate the effects of the therapy in patients with...

Sunshine Heart, C-Pulse, COUNTER HF, FDA, review, pause, enrollment

Sunshine Heart Inc. announced that the U.S. Food and Drug Administration (FDA) has reviewed the company’s submission regarding the pause of the COUNTER HF U.S. pivotal study. The FDA has requested...

radiation dose monitoring, cath lab dose monitoring, Raysafe

It’s the invisible elephant in radiology — radiation exposure. As physicians, we know all too well that exposure to radiation should be limited to the least amount possible. We have all learned...

The Society for Cardiovascular Angiography and Interventions (SCAI) announced the following late-breaking clinical trials to be presented at its 2015 Scientific Sessions, May 6-9 in San Diego.

Brilinta, AstraZeneca, FDA, sNDA, PEGASUS-TIMI 54, new indication

AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental new drug application (sNDA) and granted Priority Review for Brilinta (ticagrelor) tablets for...

Medtronic, SWIFT PRIME, REVASCAT, Solitaire, stent thrombectomy, stroke

Two global trials have found that the addition of the Solitaire device stent thrombectomy procedure to current pharmaceutical treatment significantly reduced disability in patients...

Watchman, LAA, left atrial appendage

The long awaited U.S. Food and Drug Administration (FDA) approval of the first transcatheter left atrial appendage (LAA) occluder in March is seen by many cardiologists as a disruptive technology...

COR Medical Technologies (COR) announced that Gregg W. Stone, M.D. has been appointed to its Senior Editorial Board.

Boston Scientific, Eluvia, MAJESTIC trial, vascular stent, PAD

A key trial evaluating the Boston Scientific Eluvia drug-eluting vascular stent system met its primary endpoint, with more than 94 percent of the lesions treated for peripheral arterial disease (...

Several futuristic technologies and their potential impact on healthcare were discussed during the Future of Cardiovascular Medicine track sessions at the American College of Cardiology (ACC) 2015...

The Medicines Company, cangrelor, FDA advisory committee, approval

The Medicines Company announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 9 - 2 with one abstention to recommend approval of...

Infraredx, LRP Study, TVC Imaging System, Lipid-Rich Plaques, 1,000 patients

Infraredx Inc. announced the enrollment of 1,000 patients in the Lipid-Rich Plaque (LRP) Study. The LRP Study is a prospective, multi-center clinical trial designed to identify a correlation...

Protek Duo, VV ECLS, CE mark, CardiacAssist, veno-venous cannula

CardiacAssist Inc. announced that it received a Class 3 CE-mark for its Protek Duo veno-venous cannula. The Protek Duo is licensed for use as a single cannula for both venous drainage and...

atherosclerosis, vitamin C, heart disease, Dr. Rath Research Institute

Scientific confirmation has just been published in the American Journal of Cardiovascular Disease that atherosclerosis, the underlying process of heart attacks and strokes, is generally...

CSI, Diamondback 360, atherectomy, PAD, Stealth 360

Cardiovascular Systems Inc. announced that it has received U.S. Food and Drug Administration (FDA) clearance for the 4 French, 1.25 Solid Diamondback 360 Peripheral Orbital Atherectomy System...

carotid artery stenting, F-EPD, P-EPD, ACC, embolic protection devices

A study published in JACC: Cardiovascular Interventions showed that in-hospital and 30-day stroke or death rates were equally low with either a distal filter embolic protection device (F-...

Contego Medical announced the completion of a $5.6 million Series B financing round, led by Hatteras Venture Partners. Hatteras is an early stage venture firm with a focus on medical devices,...

SCAI, survey, interventional cardiologists, work injury, orthopedic, radiation

Nearly half of interventional cardiologists responding to a survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) reported at least one work-related orthopedic...